19-51768878-T-C
Variant names:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001005738.2(FPR2):c.220T>C(p.Phe74Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0059 in 1,614,192 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0044 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0061 ( 33 hom. )
Consequence
FPR2
NM_001005738.2 missense
NM_001005738.2 missense
Scores
2
9
7
Clinical Significance
Conservation
PhyloP100: 7.36
Genes affected
FPR2 (HGNC:3827): (formyl peptide receptor 2) Enables amyloid-beta binding activity; scavenger receptor binding activity; and signaling receptor activity. Involved in several processes, including cellular response to amyloid-beta; positive regulation of monocyte chemotaxis; and regulation of defense response. Located in cytoplasm and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
FPR1 (HGNC:3826): (formyl peptide receptor 1) This gene encodes a G protein-coupled receptor of mammalian phagocytic cells that is a member of the G-protein coupled receptor 1 family. The protein mediates the response of phagocytic cells to invasion of the host by microorganisms and is important in host defense and inflammation.[provided by RefSeq, Jul 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.009210765).
BP6
Variant 19-51768878-T-C is Benign according to our data. Variant chr19-51768878-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 781747.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FPR2 | NM_001005738.2 | c.220T>C | p.Phe74Leu | missense_variant | Exon 2 of 2 | ENST00000340023.7 | NP_001005738.1 | |
FPR2 | NM_001462.3 | c.220T>C | p.Phe74Leu | missense_variant | Exon 2 of 2 | NP_001453.1 | ||
FPR2 | XM_006723120.4 | c.220T>C | p.Phe74Leu | missense_variant | Exon 3 of 3 | XP_006723183.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00438 AC: 666AN: 152180Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
666
AN:
152180
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00468 AC: 1177AN: 251488Hom.: 6 AF XY: 0.00451 AC XY: 613AN XY: 135920
GnomAD3 exomes
AF:
AC:
1177
AN:
251488
Hom.:
AF XY:
AC XY:
613
AN XY:
135920
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00606 AC: 8860AN: 1461894Hom.: 33 Cov.: 31 AF XY: 0.00576 AC XY: 4190AN XY: 727248
GnomAD4 exome
AF:
AC:
8860
AN:
1461894
Hom.:
Cov.:
31
AF XY:
AC XY:
4190
AN XY:
727248
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00437 AC: 666AN: 152298Hom.: 2 Cov.: 32 AF XY: 0.00463 AC XY: 345AN XY: 74482
GnomAD4 genome
AF:
AC:
666
AN:
152298
Hom.:
Cov.:
32
AF XY:
AC XY:
345
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
34
ALSPAC
AF:
AC:
27
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
53
ExAC
AF:
AC:
576
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
FPR2: BS2 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;.;T;T;.
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;T;.;T;D
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
.;M;.;M;M;.
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
.;D;.;.;.;.
REVEL
Uncertain
Sift
Uncertain
.;D;.;.;.;.
Sift4G
Benign
T;D;T;D;D;T
Polyphen
0.90
.;P;.;P;P;.
Vest4
0.39, 0.40
MutPred
Loss of catalytic residue at F74 (P = 0.0415);Loss of catalytic residue at F74 (P = 0.0415);Loss of catalytic residue at F74 (P = 0.0415);Loss of catalytic residue at F74 (P = 0.0415);Loss of catalytic residue at F74 (P = 0.0415);Loss of catalytic residue at F74 (P = 0.0415);
MVP
MPC
1.1
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at